Zymeworks Announces First Patient Dosed In Phase 1 Clinical Trial Evaluating ZW191 In Folate Receptor-⍺ Expressing Advanced Solid Tumors

(MENAFN - GlobeNewsWire - Nasdaq) Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW191 in treatment of advanced cancers including ovarian, endometrial, and non-small cell ...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute